Navigation Links
The Women's Heart Health Initiative announces creation of new women's cardiology research fellowship
Date:12/22/2008

New York, NY December 22, 2008 The Women's Heart Health Initiative at the Cardiovascular Research Foundation (CRF) will announce the creation of a new fellowship dedicated to gender-specific research that will improve the prevention, diagnosis and treatment of heart disease in women. The announcement will take place during a February luncheon featuring Mehmet C. Oz, MD.

"Women face unique challenges to successful diagnosis and treatment of heart disease because they develop different forms of the disease than men," said Alexandra J. Lansky, MD, Director of the Women's Heart Health Initiative, "Recommendations for the diagnosis and treatment of heart disease have historically been based on studies conducted primarily in middle-aged men. Most current trials continue to enroll too few women to determine if tests and treatments work equally well in both sexes. By establishing a research fellowship dedicated to gender-specific research, the Women's Heart Health Initiative hopes to identify treatments and preventive strategies that are effective in women and improve the outcomes and quality of life of women with or at risk for heart disease."

The Art of Living Well: A Woman's Guide to Preventing Heart Disease will take place on Wednesday, February 11, 2009 at Tavern on the Green in New York City. Dr. Mehmet C. Oz, one of America's leading physicians, will be the Keynote Speaker and lead this meaningful, in-depth discussion.


'/>"/>

Contact: Judy Romero
jromero@crf.org
212-851-9311
Cardiovascular Research Foundation
Source:Eurekalert

Page: 1

Related medicine news :

1. Womenshealthchannel Enhancements Support Pregnant Teens
2. Drug for cluster headaches may cause heart problems
3. Use of certain lipid measures not more effective in predicting coronary heart disease
4. Restricting Blood Flow May Help Heart Bypass Patients
5. Urban Smog Tough on Young Adults Hearts
6. Stanford study highlights cost-effective method of lowering heart disease risks
7. Vitamin Es lack of heart benefit linked to dosage
8. Drug That Lowers Resting Heart Rate Being Tested
9. Heart Attack Boosts Diabetes Risk
10. Embryonic Stem Cells Repair Human Heart
11. U of M study: Early treatment can reverse heart damage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2017)... , ... August 20, 2017 , ... ... HIPAA ComplyPAK™ Compliance Management System has assisted multiple clients in successfully ... Public Accountants, Service Organization Control Level 2 (AICPA SOC Level 2), and State ...
(Date:8/19/2017)... ... August 19, 2017 , ... ... will feature the Aurum Group in an upcoming episode, slated to air fourth ... Innovations will feature the Aurum Group; a company committed to supporting dentistry using ...
(Date:8/19/2017)... ... August 18, 2017 , ... ... Act of 2017, legislation that provides for greater public access to over-the-counter (OTC) ... loss to access OTC hearing aids without being seen by a certified and ...
(Date:8/19/2017)... ... August 19, 2017 , ... Praeclarus Press has launched a ... show the diversity of the breastfeeding mothers, using bright colors and contemporary ... These illustrations are also available on tote bags, notepads, smartphone cases, clocks, and ...
(Date:8/19/2017)... ... August 19, 2017 , ... Physician ... its Orlando location as an interventional pain management physician. He brings a wealth ... treatment of migraine headaches, and significant experience in spinal cord stimulation for chronic ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... Aug. 7, 2017 Diplomat Pharmacy, Inc. (NYSE: ... Saban as president, effective Aug. 7, 2017. ... decided to pursue other interests and will serve as president ... Paul has served us in multiple leadership roles since he ... Jun. 2015 and has provided decisive, strategic leadership which continues ...
(Date:8/7/2017)... 2017  Endo International plc (NASDAQ: ENDP ... virtually all known U.S. mesh product liability claims and ... known remaining U.S. claims at reasonable values. Under the ... fourth quarter of 2017 and continuing through the fourth ... 2017 results, the Company intends to increase its mesh ...
(Date:8/4/2017)... CINCINNATI , Aug. 3, 2017  Agragen, ... science company active in the biopharmaceutical, nutraceutical, and ... its development of its lead drug candidates, AGR131.  ... a proinflammatory cytokine from the blood of patients ... psoriasis, and inflammatory bowel disease. ...
Breaking Medicine Technology: